Q2 2023 Holdings
Filed 2023-08-14 | 20 holdings | $2.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Moderna Inc(MRNA) | COM | 60770K107 | $1.6B | 12,886,743 | 69.9% |
| Sana Biotechnology Inc(SANA) | COM | 799566104 | $198.4M | 33,290,018 | 8.9% |
| Omega Therapeutics Inc | COM | 68217N105 | $163.7M | 29,225,579 | 7.3% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $110.7M | 23,117,045 | 4.9% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $89.2M | 12,674,120 | 4.0% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $77.3M | 2,619,968 | 3.5% |
| Sigilon Therapeutics Inc | COM | 82657L206 | $18.0M | 797,720 | 0.8% |
| Evelo Biosciences Inc(EVLO) | COM | 299734202 | $8.2M | 2,521,369 | 0.4% |
| Axcella Health Inc | COM | 05454B105 | $6.4M | 29,251,545 | 0.3% |
| Syros Pharmaceuticals Inc(SYRS) | COM | 87184Q206 | $3.1M | 993,848 | 0.1% |